DOI : 10.1055/s-00000059

Pneumologie

Issue S 01 · Volume 74 · March 2020 DOI: 10.1055/s-010-46041


61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.
Leipzig, 25.–28.03.2020

Kongresspräsident: Prof. Dr. med. Gernot Rohde
Abstracts (HTML) Abstracts (PDF) List of Authors
P343
DʼAndrea, P; Kornmann, O; Mucsi, J; Kato, M; Bandelli, L: Efficacy and safety of once-daily IND-MF in symptomatic adult and adolescent patients with inadequately controlled asthma: findings from the Phase III randomized QUARTZ study
P362
Gil, EG; Shaw, D; Menzies-Gow, A; Bourdin, A; Barker, P: Reduced Long-term Cumulative OCS Exposure for Benralizumab-Treated Patients with Severe Asthma
P361
Cook, W; Upham, JW; Jackson, DJ; Barker, P; Newbold, P: Baseline Predictors of Being Exacerbation-Free During 2 Years of Benralizumab Treatment
P385
Albers, FC; Khurana, S; Bradford, E; Gilson, M; Price, R; Brusselle, G; Bel, E; FitzGerald, JM; Masoli, M; Korn, S; Humbert, M: Long-term safety and durability of mepolizumab in life-threatening/seriously debilitating severe eosinophilic asthma (SEA): COSMEX
P386
Harrison, T; Canonica, G; Gemzoe, K; Maxwell, A; Yang, S; Joksaite, S; OʼReilly, R; Van Dyke, M; Albers, FC; Kwon, N: Effectiveness and safety of mepolizumab in real-world clinical practice: The REALITI-A study
P395
Evitt, LA; Follows, R; Williams, W; Shalhoub, H; Celone, M; Yang, S; von Maltzahn, R: Mepolizumab self-administration via autoinjector and prefilled syringe: the qualitative patient experience
P396
Evitt, LA; Follows, R; Bentley, JH; Williams, W; von Maltzahn, R: Self-administration of mepolizumab via an autoinjector: the patient experience
P353
Gil, EG; Jackson, DJ; Humbert, M; Hirsch, I; Newbold, P: Association of Baseline Blood Eosinophil Counts and Serum IgE Concentrations on Exacerbations and Benralizumab Efficacy for Patients with Severe, Uncontrolled Asthma
P104
Schmidt, O; Hanrath, V: „Rheinland-Pfalz atmet durch – Telemedizin für eine gesunde Lunge“ – Telemedizin wird von Asthmatikern angenommen und verbessert deren Lebensqualität
P348
Schmidt, O; Nan, C; Lindner, R; Ilgin, Y; Schultz, T; Gylvin, L; Bleecker, ER: Short-term and Maintenance Oral Corticosteroid Use for German Patients with Asthma
P332
Lommatzsch, M; Shavit, A; Grund, T; Watz, H; Korn, S: Change in measured Patient-Reported Outcomes in severe eosinophilic asthma patients treated with benralizumab under real life conditions in Germany (imPROve asthma study) – Study Design
P257
Worth, H; Criée, CP; Schneider, A; Vogelmeier, C; Kardos, P; Becker, E; Kostev, K; Mokros, I: Retrospektive Analyse zum Einsatz kurzwirksamer Beta-2-Sympathomimetika (SABA) bei Patienten mit Asthma in Deutschland
P471
Lommatzsch, M; Wilmer, C; Schwab Sauerbeck, I: Systemic corticosteroid use in relation to development of corticosteroid-associated co-morbidities: a 2 year analysis of real world data in Germany
P309
Buhl, R; Tanase, AM; Hosoe, M; Cao, W; Demin, I; Bartels, C; Jauernig, J; Ziegler, D; Patalano, F; Hederer, B; Kannies, F; Tillmann, HC: Mometasone furoate delivered via Breezhaler® and Twisthaler® in patients with asthma